Page last updated: 2024-10-31

nocodazole and Niemann-Pick Diseases

nocodazole has been researched along with Niemann-Pick Diseases in 2 studies

Niemann-Pick Diseases: A group of autosomal recessive disorders in which harmful quantities of lipids accumulate in the viscera and the central nervous system. They can be caused by deficiencies of enzyme activities (SPHINGOMYELIN PHOSPHODIESTERASE) or defects in intracellular transport, resulting in the accumulation of SPHINGOMYELINS and CHOLESTEROL. There are various subtypes based on their clinical and genetic differences.

Research Excerpts

ExcerptRelevanceReference
"Amiodarone analogues were also studied, including the recently developed derivative dronedarone."1.37Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype. ( Baritussio, A; Bergonzini, V; Bigler, L; Calistri, A; Caretta, CM; Dal Zoppo, D; Del Vecchio, C; Faggin, E; Ha, HR; Nadai, M; Orlando, R; Palù, G; Pettenazzo, A; Piccoli, E; Salata, C, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Piccoli, E1
Nadai, M1
Caretta, CM1
Bergonzini, V1
Del Vecchio, C1
Ha, HR1
Bigler, L1
Dal Zoppo, D1
Faggin, E1
Pettenazzo, A1
Orlando, R1
Salata, C1
Calistri, A1
Palù, G1
Baritussio, A1
Lange, Y1
Ye, J1
Rigney, M1
Steck, TL1

Other Studies

2 other studies available for nocodazole and Niemann-Pick Diseases

ArticleYear
Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype.
    Biochemical pharmacology, 2011, Nov-01, Volume: 82, Issue:9

    Topics: Amiodarone; Androstenes; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Cholesterol; Dose-Respons

2011
Dynamics of lysosomal cholesterol in Niemann-Pick type C and normal human fibroblasts.
    Journal of lipid research, 2002, Volume: 43, Issue:2

    Topics: Amphotericin B; Androstenes; Anti-Bacterial Agents; Anticholesteremic Agents; Antineoplastic Agents;

2002